Palvella Therapeutics (PVLA) Receivables - Other (2014 - 2024)

Palvella Therapeutics (PVLA) has 4 years of Receivables - Other data on file, last reported at $506000.0 in Q3 2024.

• On a quarterly basis, Receivables - Other changed N/A year-over-year to $506000.0 in Q3 2024; TTM through Sep 2024 was $506000.0, a N/A change from a year earlier, with the FY2023 full-year figure at $2.3 million, up 403.46% from the prior year.
• Receivables - Other for Q3 2024 stood at $506000.0, up from $137000.0 in the prior quarter.
• Over the last five years, Receivables - Other for PVLA reached as high as $2.3 million in Q1 2024 and fell as low as $137000.0 in Q2 2024.
• Historically, Receivables - Other has averaged $1.2 million across 3 years, with a median of $506000.0 in 2024.
• On a YoY basis, Receivables - Other climbed as much as 403.46% in 2023 and fell as far as 403.46% in 2023.
• Year by year, Receivables - Other stood at $462000.0 in 2022, then jumped by 403.46% to $2.3 million in 2023, then plunged by 78.25% to $506000.0 in 2024.
• Per Business Quant data, the three most recent Receivables - Other figures were $506000.0 in Q3 2024, $137000.0 in Q2 2024, and $2.3 million in Q1 2024.